New Covenant Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$286K Buy
10,042
+159
+2% +$4.23K 0.2% 85
2026
Q2
$238K Buy
9,883
+752
+8% +$19.7K 0.18% 92
2026
Q1
$256K Buy
9,131
+1,133
+14% +$30.2K 0.23% 76
2025
Q4
$201K Buy
+7,998
New +$202K 0.18% 90
2025
Q2
– Sell
-8,047
Closed -$203K – 89
2025
Q1
$203K Sell
8,047
-113
-1% -$2.96K 0.21% 86
2024
Q4
$216K Sell
8,160
-834
-9% -$22.6K 0.21% 81
2024
Q3
$262K Buy
8,994
+1,261
+16% +$36.8K 0.25% 70
2024
Q2
$232K Sell
7,733
-208
-3% -$5.73K 0.27% 67
2024
Q1
$220K Buy
+7,941
New +$220K 0.22% 72

Other funds holding PFE

New Covenant Trust Company's PFE Position: Q3 2026 in Review

New Covenant Trust Company increased its Pfizer (PFE) stake by 1.6% in Q3 2026, buying an estimated $4.23K and bringing the position to 10,042 shares worth $286K. The position accounts for 0.2% of the portfolio, ranked #85.

New Covenant Trust Company first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • New Covenant Trust Company held 10,042 shares of Pfizer worth $286K as of Q3 2026.
  • New Covenant Trust Company bought 159 Pfizer shares in Q3 2026, an estimated $4.23K.
  • Pfizer made up 0.2% of New Covenant Trust Company's portfolio in Q3 2026, its #85 holding.
  • New Covenant Trust Company first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on New Covenant Trust Company's 13F filing for Q3 2026, filed 8 Oct 2026.